Modulation in the IL-21 and IL-22 system may affect the course of the inflammatory process that accompanies the development of cancer, which may prove useful in the development of new diagnostic and therapeutic strategies used in patients with ovarian cancer, which requires further studies. Here, IL22 is linked to ovarian cancer.